Kymera
degradation in blood at dose level consistent with prediction from preclinical modeling | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
13 of 63
Related slides by other companies
Uber
Results
May 2023
rider cohorts engaging and spending more on | Uber
Melrose
Investor Conference
November 2021
key financial numbers increasing momentum | Melrose
Rover
Investor Presentation
November 2023
strong lifetime value increasing and repeat bookings drive strength of in recent cohorts average months since first booking incomplete cohort year since inception cohorts have demonstrated positive long term trends cohorts were impacted by covid subsequent incremental trends have recovered to expected levels and other non covid credit card pome peace i i ere | Rover
FL Entertaiment
SPAC
May 2022
compelling valuation levels | FL Entertaiment
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights